Showing results (11-20 of 79) with videos related to
Sort By:
Pageof 8
Biochimica Et Biophysica Acta|April 4, 2015
5-HT3 receptors as important mediators of nausea and vomiting due to chemotherapyRudolph M NavariSupportive Cancer Therapy|July 17, 2008
Inhibiting substance p pathway for prevention of chemotherapy-induced emesis: preclinical data, clinical trials of neurokinin-1 receptor antagonistsRudolph M NavariFuture Oncology (London, England)|October 10, 2006
Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonistRudolph M NavariExpert Opinion on Drug Safety|December 25, 2015
The safety of antiemetic medications for the prevention of chemotherapy-induced nausea and vomitingRudolph M NavariBiomed Research International|October 1, 2015
Treatment of Breakthrough and Refractory Chemotherapy-Induced Nausea and VomitingRudolph M NavariExpert Opinion on Pharmacotherapy|October 18, 2014
Palonosetron for the treatment of chemotherapy-induced nausea and vomitingRudolph M NavariPaediatric Drugs|April 28, 2017
Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric PatientsRudolph M NavariDrug Design, Development and Therapy|January 2, 2015
Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV)Rudolph M NavariCancer Investigation|November 30, 2004
Role of neurokinin-1 receptor antagonists in chemotherapy-induced emesis: summary of clinical trialsRudolph M NavariThe Journal of Supportive Oncology|September 9, 2004
Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agentsRudolph M NavariPageof 8